| Insideraktier | 27.213.159 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Reneo Pharmaceuticals, Inc. insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i RPHM / Reneo Pharmaceuticals, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i RPHM / Reneo Pharmaceuticals, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-07 | 3 | AI Biotechnology LLC | OKUR | Class A Common Stock | D | 3.998.332 | ||||||||
| 2026-03-24 | 2026-03-23 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 4,1565 | -301 | -1 | 16.000 | ||||
| 2026-03-24 | 2026-03-23 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 4,1565 | -86 | -0 | 7.333 | ||||
| 2026-01-02 | 2025-12-31 | 4 | Mathers Edward T | OKUR | Class A Common Stock | D | 3.911 | 15.310 | ||||||
| 2026-01-02 | 2025-12-31 | 4 | Manke Isaac | OKUR | Class A Common Stock | D | 5.258 | 20.583 | ||||||
| 2025-12-23 | 2025-12-22 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 2,9677 | -87 | -0 | 7.419 | ||||
| 2025-12-23 | 2025-12-22 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 2,9677 | -302 | -1 | 16.301 | ||||
| 2025-10-02 | 2025-09-30 | 4 | Mathers Edward T | OKUR | Class A Common Stock | D | 4.125 | 11.399 | ||||||
| 2025-10-02 | 2025-09-30 | 4 | Manke Isaac | OKUR | Class A Common Stock | D | 5.545 | 15.325 | ||||||
| 2025-09-24 | 2025-09-22 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 2,6235 | -88 | -0 | 3.506 | ||||
| 2025-09-24 | 2025-09-22 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 2,6235 | -303 | -1 | 12.603 | ||||
| 2025-07-02 | 2025-06-30 | 4 | Mathers Edward T | OKUR | Class A Common Stock | D | 4.694 | 7.274 | ||||||
| 2025-07-02 | 2025-06-30 | 4 | Manke Isaac | OKUR | Class A Common Stock | D | 6.311 | 9.780 | ||||||
| 2025-06-25 | 2025-06-23 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 2,3842 | -88 | -0 | 3.594 | ||||
| 2025-06-25 | 2025-06-23 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 2,3842 | -303 | -1 | 12.906 | ||||
| 2025-05-27 | 3 | Acorn Capital Advisors GP 2, LLC | OKUR | Common Stock | D | 1.129.730 | ||||||||
| 2025-05-19 | 2025-05-15 | 4 | ACORN BIOVENTURES, L.P. By Acorn Bioventures 2, L.P. | OKUR | Common Stock | I | 1,8500 | 1.129.730 | 2.090 | 1.129.730 | ||||
| 2025-05-19 | 2025-05-15 | 4 | ACORN BIOVENTURES, L.P. | OKUR | Common Stock | D | 1,8500 | 270.270 | 500 | 1.709.944 | ||||
| 2025-05-19 | 2025-05-15 | 4 | Cormorant Asset Management, LLC | OKUR | Class A Common Stock | I | 1,8545 | -1.813.439 | -3.363 | 0 | ||||
| 2025-05-14 | 2025-05-12 | 4 | Cormorant Asset Management, LLC See Footnotes | OKUR | Class A Common Stock | I | 1,9850 | -24.300 | -48 | 1.813.439 | ||||
| 2025-04-08 | 2025-04-07 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 2,6710 | -516 | -1 | 3.682 | ||||
| 2025-04-08 | 2025-04-04 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 3,3276 | -358 | -1 | 4.198 | ||||
| 2025-04-08 | 2025-04-07 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 2,6710 | -1.844 | -5 | 13.209 | ||||
| 2025-04-08 | 2025-04-04 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 3,3276 | -1.278 | -4 | 15.053 | ||||
| 2025-04-02 | 2025-03-31 | 4 | Mathers Edward T | OKUR | Class A Common Stock | D | 2.580 | 2.580 | ||||||
| 2025-04-02 | 2025-03-31 | 4 | Manke Isaac | OKUR | Class A Common Stock | D | 3.469 | 3.469 | ||||||
| 2024-10-15 | 3 | Cormorant Asset Management, LLC See Footnotes | OKUR | Class A Common Stock | I | 1.837.739 | ||||||||
| 2024-10-09 | 3 | ACORN BIOVENTURES, L.P. | OKUR | Class A Common Stock | D | 1.439.674 | ||||||||
| 2024-10-09 | 2024-10-07 | 4 | Leonard Braden Michael | OKUR | Common Stock | D | 102.076 | 102.076 | ||||||
| 2024-10-09 | 2024-10-07 | 4 | Leonard Braden Michael Holdings of BML Investment Partners, L.P. | OKUR | Common Stock | I | 345.739 | 345.739 | ||||||
| 2024-10-08 | 2024-10-04 | 4 | Saccomano Nicholas A | OKUR | Class A Common Stock | D | 4.556 | 4.556 | ||||||
| 2024-10-08 | 2024-10-04 | 4 | Leverone Jason A. | OKUR | Class A Common Stock | D | 16.331 | 16.331 | ||||||
| 2024-10-08 | 2024-10-04 | 4 | Carruthers R Michael | OKUR | Class A Common Stock | D | 4.065 | 4.939 | ||||||
| 2024-10-08 | 2024-10-04 | 4 | Carruthers R Michael | OKUR | Class A Common Stock | D | 874 | 874 | ||||||
| 2024-09-26 | 2024-09-25 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,4964 | 68.746 | 103 | 3.457.395 | ||||
| 2024-09-26 | 2024-09-24 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,4144 | 29.600 | 42 | 3.388.649 | ||||
| 2024-09-19 | 2024-09-18 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,4000 | 806 | 1 | 3.359.049 | ||||
| 2024-09-19 | 2024-09-17 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,3582 | 55.300 | 75 | 3.358.243 | ||||
| 2024-09-16 | 2024-09-16 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,3712 | 172.747 | 237 | 3.302.943 | ||||
| 2024-09-16 | 2024-09-13 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,3130 | 150.000 | 197 | 3.130.196 | ||||
| 2024-09-16 | 2024-09-12 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,3966 | 36.176 | 51 | 2.980.196 | ||||
| 2024-08-14 | 2024-08-14 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,4132 | 100.487 | 142 | 2.944.020 | ||||
| 2024-08-14 | 2024-08-13 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,3925 | 171.339 | 239 | 2.843.533 | ||||
| 2024-05-16 | 2024-05-14 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,5400 | 335.000 | 516 | 2.672.194 | ||||
| 2024-05-16 | 2024-05-14 | 4 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 1,5600 | 79.281 | 124 | 2.337.194 | ||||
| 2024-05-16 | 3 | Leonard Braden Michael | RPHM | Common Stock | D | 1.020.769 | ||||||||
| 2024-05-16 | 3 | Leonard Braden Michael Holding of BML Investment Partners, L.P. | RPHM | Common Stock | I | 2.672.194 | ||||||||
| 2023-08-29 | 2023-08-28 | 4 | Hall Ashley | RPHM | Common Stock | D | 6,2757 | -15.625 | -98 | 39.600 | ||||
| 2023-08-29 | 2023-08-28 | 4 | Hall Ashley | RPHM | Common Stock | D | 1,8000 | 15.625 | 28 | 55.225 | ||||
| 2023-07-27 | 2023-07-26 | 4 | GREY MICHAEL G | RPHM | Common Stock | D | -50.000 | 0 | ||||||
| 2023-06-23 | 2023-06-23 | 4 | Novo A/S | RPHM | Common Stock | D | 7,0974 | -100.000 | -710 | 3.330.337 | ||||
| 2023-05-10 | 2023-05-08 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Common Stock | I | 8,0000 | 125.000 | 1.000 | 2.188.713 | ||||
| 2022-12-13 | 2022-08-12 | 4 | Dorenbaum Alejandro | RPHM | Common Stock | D | -22.348 | 30.000 | ||||||
| 2022-09-02 | 2022-09-01 | 4 | Cruse Michael by Trust | RPHM | Common Stock | I | 3,3930 | 7.500 | 25 | 13.697 | ||||
| 2022-09-02 | 2022-08-31 | 4 | GREY MICHAEL G | RPHM | Common Stock | D | 1,9700 | 50.000 | 98 | 50.000 | ||||
| 2022-08-31 | 2022-08-31 | 4 | Cruse Michael by Trust | RPHM | Common Stock | I | 3,2090 | 3.212 | 10 | 6.197 | ||||
| 2022-08-31 | 2022-08-30 | 4 | Cruse Michael by Trust | RPHM | Common Stock | I | 3,1938 | 1.845 | 6 | 2.985 | ||||
| 2022-08-31 | 2022-08-30 | 4 | Cruse Michael | RPHM | Common Stock | D | 3,1600 | 975 | 3 | 31.758 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Cruse Michael by Trust | RPHM | Common Stock | I | 3,2400 | 1.140 | 4 | 1.140 | ||||
| 2022-08-31 | 2022-08-29 | 4 | Cruse Michael | RPHM | Common Stock | D | 3,2400 | 83 | 0 | 30.783 | ||||
| 2022-04-05 | 3 | Lam Jennifer | RPHM | Common Stock | D | 15.000 | ||||||||
| 2022-03-04 | 2022-03-02 | 4 | Cruse Michael | RPHM | Stock option (right to buy) | D | 4,58 | 25.000 | 25.000 | |||||
| 2022-01-24 | 2022-01-20 | 4 | Hoelscher Paul W. | RPHM | Stock Option (right to buy) | D | 8,01 | 35.000 | 35.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Jindal Vineet R. | RPHM | Stock option (right to buy) | D | 6,69 | 100.000 | 100.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Jindal Vineet R. | RPHM | Common Stock | D | 30.000 | 36.600 | ||||||
| 2021-12-14 | 2021-12-10 | 4 | FLESHER GREGORY J. | RPHM | Stock option (right to buy) | D | 6,69 | 200.000 | 200.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | FLESHER GREGORY J. | RPHM | Common Stock | D | 100.000 | 109.600 | ||||||
| 2021-12-14 | 2021-12-10 | 4 | Dorenbaum Alejandro | RPHM | Stock option (right to buy) | D | 6,69 | 100.000 | 100.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Dorenbaum Alejandro | RPHM | Common Stock | D | 30.000 | 52.348 | ||||||
| 2021-12-14 | 2021-12-10 | 4 | Cruse Michael | RPHM | Stock option (right to buy) | D | 6,69 | 75.000 | 75.000 | |||||
| 2021-12-14 | 2021-12-10 | 4 | Cruse Michael | RPHM | Common Stock | D | 25.000 | 29.100 | ||||||
| 2021-11-15 | 2021-11-12 | 4 | Hall Ashley | RPHM | Stock Option (right to buy) | D | 8,85 | 180.000 | 180.000 | |||||
| 2021-11-15 | 2021-11-12 | 4 | Hall Ashley | RPHM | Common Stock | D | 30.000 | 30.000 | ||||||
| 2021-08-26 | 2021-08-25 | 4 | Jindal Vineet R. | RPHM | Common Stock | D | 7,4353 | 5.000 | 37 | 5.000 | ||||
| 2021-08-26 | 2021-08-25 | 4 | FLESHER GREGORY J. | RPHM | Common Stock | D | 8,0000 | 8.000 | 64 | 8.000 | ||||
| 2021-08-26 | 2021-08-25 | 4 | Cruse Michael | RPHM | Common Stock | D | 7,4464 | 2.500 | 19 | 2.500 | ||||
| 2021-07-15 | 2021-07-14 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 8,5000 | 111.736 | 950 | 2.073.957 | ||||
| 2021-07-15 | 2021-07-14 | 4 | Johnson Wendy S. | RPHM | Common Stock | D | 8,5000 | -111.736 | -950 | 0 | ||||
| 2021-07-09 | 2021-07-08 | 4 | Johnson Wendy S. | RPHM | Stock option (right to buy) | D | 1,97 | -111.736 | 0 | |||||
| 2021-07-09 | 2021-07-08 | 4 | Johnson Wendy S. | RPHM | Common Stock | D | 1,9700 | 111.736 | 220 | 111.736 | ||||
| 2021-06-25 | 2021-06-23 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,2827 | 20.710 | 192 | 1.962.221 | ||||
| 2021-06-23 | 2021-06-22 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 8,7230 | 14.615 | 127 | 1.941.511 | ||||
| 2021-06-23 | 2021-06-21 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,0305 | 32.659 | 295 | 1.926.896 | ||||
| 2021-06-10 | 2021-06-08 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,4977 | 16.605 | 158 | 1.894.237 | ||||
| 2021-06-07 | 2021-06-04 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,4242 | 257 | 2 | 1.877.632 | ||||
| 2021-06-07 | 2021-06-03 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,2515 | 12.100 | 112 | 1.877.375 | ||||
| 2021-06-02 | 2021-05-28 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,5000 | 14 | 0 | 1.865.275 | ||||
| 2021-05-28 | 2021-05-27 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,2583 | 1.120 | 10 | 1.865.261 | ||||
| 2021-05-28 | 2021-05-26 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 9,3821 | 5.915 | 55 | 1.864.141 | ||||
| 2021-04-15 | 2021-04-13 | 4 | New Enterprise Associates 15, L.P. | RPHM | Series B Preferred Stock | D | -8.904.280 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | New Enterprise Associates 15, L.P. | RPHM | Series A Preferred Stock | D | -9.526.652 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | New Enterprise Associates 15, L.P. | RPHM | Common Stock | D | 15,0000 | 666.666 | 10.000 | 4.785.494 | ||||
| 2021-04-15 | 2021-04-13 | 4 | New Enterprise Associates 15, L.P. | RPHM | Common Stock | D | 1.989.872 | 4.118.828 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | New Enterprise Associates 15, L.P. | RPHM | Common Stock | D | 2.128.956 | 2.128.956 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Series B Preferred Stock | I | -3.710.116 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Series A Preferred Stock | I | -4.629.630 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Common Stock | I | 15,0000 | 200.000 | 3.000 | 2.063.713 | ||||
| 2021-04-15 | 2021-04-13 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Common Stock | I | 829.113 | 1.863.713 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | O'Donnell Niall By RiverVest Venture Fund IV, L.P. | RPHM | Common Stock | I | 1.034.600 | 1.034.600 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Series B Preferred Stock | I | -7.420.232 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 15,0000 | 200.000 | 3.000 | 1.858.226 | ||||
| 2021-04-15 | 2021-04-13 | 4 | Muralidhar Bali By Abingworth Bioventures 8 LP | RPHM | Common Stock | I | 1.658.226 | 1.658.226 | ||||||
| 2021-04-15 | 3/A | GREY MICHAEL G | RPHM | Common Stock | I | 424.600 | ||||||||
| 2021-04-15 | 2021-04-13 | 4 | GREY MICHAEL G | RPHM | Series A Preferred Stock | I | -90.222 | 0 | ||||||
| 2021-04-15 | 2021-04-13 | 4 | GREY MICHAEL G | RPHM | Common Stock | I | 20.162 | 444.762 | ||||||
| 2021-04-14 | 2021-04-13 | 4 | Novo A/S | RPHM | SERIES B CONVERTIBLE PREFERRED STOCK | D | -12.367.054 | 0 | ||||||
| 2021-04-14 | 2021-04-13 | 4 | Novo A/S | RPHM | COMMON STOCK | D | 15,0000 | 666.666 | 10.000 | 3.430.377 | ||||
| 2021-04-14 | 2021-04-13 | 4 | Novo A/S | RPHM | COMMON STOCK | D | 2.763.711 | 2.763.711 | ||||||
| 2021-04-13 | 2021-04-09 | 4 | RiverVest Venture Fund III, L.P. | RPHM | Series B Preferred Stock | I | -3.710.116 | 0 | ||||||
| 2021-04-13 | 2021-04-09 | 4 | RiverVest Venture Fund III, L.P. | RPHM | Series A Preferred Stock | I | -4.925.711 | 0 | ||||||
| 2021-04-13 | 2021-04-09 | 4 | RiverVest Venture Fund III, L.P. | RPHM | Common Stock | I | 15,0000 | 200.000 | 3.000 | 2.409.220 | ||||
| 2021-04-13 | 2021-04-09 | 4 | RiverVest Venture Fund III, L.P. | RPHM | Common Stock | I | 829.113 | 2.209.220 | ||||||
| 2021-04-13 | 2021-04-09 | 4 | RiverVest Venture Fund III, L.P. | RPHM | Common Stock | I | 1.100.765 | 1.380.107 | ||||||
| 2021-04-12 | 2021-04-08 | 4 | Cardon Lon | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | Harrison Kenneth Ph.D. | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | Seltzer Stacey Denenberg | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | GREY MICHAEL G | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | O'Donnell Niall | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | Muralidhar Bali | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-12 | 2021-04-08 | 4 | Mathers Edward T | RPHM | Stock Option (right to buy) | D | 15,00 | 14.000 | 14.000 | |||||
| 2021-04-08 | 3 | RiverVest Venture Fund IV, L.P. | RPHM | Common Stock | I | 279.342 | ||||||||
| 2021-04-08 | 3 | GREY MICHAEL G | RPHM | Common Stock | I | 134.084 | ||||||||
| 2021-04-08 | 3 | GREY MICHAEL G | RPHM | Common Stock | I | 424.601 | ||||||||
| 2021-04-08 | 3 | Dorenbaum Alejandro | RPHM | Common Stock | D | 22.348 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
